flumazenil   Click here for help

GtoPdb Ligand ID: 4192

Synonyms: Anexate® | Ro15-1788
Approved drug PDB Ligand
flumazenil is an approved drug (FDA (1991))
Compound class: Synthetic organic
Comment: Flumazenil reverses the effects of benzodiazepine sedatives.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 0
Rotatable bonds 3
Topological polar surface area 63.91
Molecular weight 303.1
XLogP 2.92
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)F
Isomeric SMILES CCOC(=O)c1ncn2c1CN(C)C(=O)c1c2ccc(c1)F
InChI InChI=1S/C15H14FN3O3/c1-3-22-15(21)13-12-7-18(2)14(20)10-6-9(16)4-5-11(10)19(12)8-17-13/h4-6,8H,3,7H2,1-2H3
InChI Key OFBIFZUFASYYRE-UHFFFAOYSA-N
Bioactivity Comments
Flumazenil is non-selective in action, but is most potent at GABAA receptors containing the α1, α3 and α5 subunits [1].
Selectivity at ion channels
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
GABAA receptor α5 subunit Primary target of this compound Hs Allosteric modulator - 9.2 pKi - 3
pKi 9.2 (Ki 6x10-10 M) [Binds to: benzodiazepine site] Antagonist at α1 receptors, but allosteric modulator at other subtypes. [3]
Description: Affinity measured using α5β3γ2 receptors.
GABAA receptor α1 subunit Primary target of this compound Hs Allosteric modulator Antagonist 9.1 pKi - 3
pKi 9.1 (Ki 8x10-10 M) [Binds to: benzodiazepine site] Antagonist at α1 receptors, but allosteric modulator at other subtypes. [3]
Description: Affinity measured using α1β3γ2 receptors.
GABAA receptor α2 subunit Primary target of this compound Hs Allosteric modulator - 9.1 pKi - 3
pKi 9.1 (Ki 9x10-10 M) [Binds to: benzodiazepine site] Antagonist at α1 receptors, but allosteric modulator at other subtypes. [3]
Description: Affinity measured using α2β3γ2 receptors.
GABAA receptor α3 subunit Primary target of this compound Hs Allosteric modulator - 9.0 pKi - 2-3
pKi 9.0 (Ki 1.05x10-9 M) [Binds to: benzodiazepine site] Antagonist at α1 receptors, but allosteric modulator at other subtypes. [2-3]
Description: Affinity measured using α3β3γ2 receptors.
GABAA receptor α4 subunit Rn Allosteric modulator Positive 7.0 pKi - 4
pKi 7.0 (Ki 9.4x10-8 M) Antagonist at α1 receptors, but allosteric modulator at other subtypes. [4]
Description: Antagonism of complexes containing α4β2γ2 subunits heterologously expressed in vitro.
GABAA receptor α6 subunit Hs Allosteric modulator Partial agonist 6.8 pKi - 3
pKi 6.8 (Ki 1.48x10-7 M) [Binds to: benzodiazepine site] low affinity [3]
Description: Affinity measured using α6β3γ2 receptors.